glp 1 comparison GLP-1 Drug in Diabetes and Obesity Treatment GLP-1 Drug Savings: A Complete
Description
Glucagon-like peptide 1 is produced in the gut as a result of eating food and it appears that its primary roles are to inhibit the production of glucagon and to promote the production of insulin

31 118905.e13

Are GLP-1 tablets as effective as injections

Elderly patients Older adults are at higher risk for hypoglycemia with insulin therapy, including Toujeo

The assay has been validated with both GLP-1 (7-36), the endogenous physiological full agonist secreted by intestinal L-cells, and its metabolite GLP1 (9-36) which is a weaker partial agonist

Since GIPs may also enhance glucagon secretion, it has little pharmacological significance and thus considered not useful as a pharmacological agent for Diabetes treatment
